A consumer watchdog has issued a warning about the health risks associated with intravenous (IV) skin-lightening drips, which contain glutathione, an unlicensed antioxidant.

The Chartered Trading Standards Institute (CTSI) has called for urgent regulation of this sector, highlighting the significant safety risks posed by unregulated administration of these procedures.

Health risks linked to these treatments include potential liver and kidney strain, allergic reactions, and infections due to improper hygiene practices.

An investigation by Channel 4 News revealed that over 300 beauty salons and clinics in the UK offer these drips, many of which are not operated by qualified medical professionals.

Consultant dermatologist Dr. Ophelia Dadzie criticized the lack of regulatory oversight, calling for a halt to IV glutathione offerings until regulations are established.

Andrew Rankin from the Joint Council for Cosmetic Practitioners reiterated the dangers of using unlicensed glutathione and urged the government to regulate such procedures.

A spokesperson from the Department of Health and Social Care encouraged individuals to consider health impacts and consult qualified practitioners for cosmetic procedures, noting ongoing efforts to regulate the non-surgical cosmetics sector.

The Medicines and Healthcare products Regulatory Agency (MHRA) clarified that claims related to skin lightening are not considered medicinal, but will take action if products are sold without proper authorizations.

These skin-lightening drips are marketed on social media with before-and-after videos, and their costs typically range from £75 to £100.

Kerry Nicol from the CTSI expressed shock at the prevalence of these procedures, emphasizing that they do not meet UK safety standards.

Campaign group Safety in Beauty supports the call for regulation, citing the dangers of unregulated treatments.

The treatments, known as skin whitening or brightening drips, raise significant safety concerns due to the lack of clinical oversight and accountability.